Company intelligence / Profile preview

FAL Duiven

Duiven, Gelderland, Netherlandsfalduiven.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

FAL Duiven specializes in developing oral solid dosage forms for human use, registering these products primarily in the Dutch and EU markets. The company licenses dossiers to third parties for registration in other territories and manufactures/supplies these products to partners. It is known for analytical services including regulatory support, stability testing, method development/validation, and quality control

Therapeutic areas: Psychiatry
Modalities: Small molecule
Industry: Biotech

Partnerships

Licensing partnerships with third parties across EU/non-EU territories

Beyond the preview

Go deeper on FAL Duiven.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FAL Duiven.

Explore the full profile